Showing results (2171-2180 of 2,345) with videos related to
Sort By:
Pageof 235
Journal of Medicinal Chemistry|November 1, 2002
Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug designIngrid C Choong, Willard Lew, Dennis Lee, et al.Frontiers in Neuroscience|July 3, 2015
Multidimensional frequency domain analysis of full-volume fMRI reveals significant effects of age, gender, and mental illness on the spatiotemporal organization of resting-state brain activityRobyn L Miller, Erik B Erhardt, Oktay Agcaoglu, et al.Physical Review Letters|April 6, 2001
Anomalous elastic response of silicon to uniaxial shock compression on nanosecond time scalesA Loveridge-Smith, A Allen, J Belak, et al.Neuroimage. Clinical|August 28, 2014
Dynamic functional connectivity analysis reveals transient states of dysconnectivity in schizophreniaE Damaraju, E A Allen, A Belger, et al.MDM Policy & Practice|October 25, 2021
Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart FailureMary C Thomson, Larry A Allen, Scott D Halpern, et al.JACC. Heart Failure|September 12, 2021
Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionAnthony P Carnicelli, Zhen Li, Melissa A Greiner, et al.Expert Review of Clinical Immunology|April 29, 2025
Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseasesKelly G Gwathmey, Catherine M Broome, Matthias Goebeler, et al.JAMA Cardiology|July 21, 2016
Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF RegistryJonathan P Piccini, DaJuanicia N Simon, Benjamin A Steinberg, et al.The American Journal of Cardiology|August 6, 2023
Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System InhibitorsJacob B Pierce, Vanessa Blumer, Sujung Choi, et al.Plos Pathogens|March 8, 2013
Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadthMegan K Murphy, Ling Yue, Ruimin Pan, et al.Pageof 235